Trial intelligence / Profile preview

Budesonide Irrigation vs Fluticasone Spray in Post-FESS CRSwNP

NCT02194062Completed

Sponsor
Yale University
Start
Jan 2015
Primary completion
Jul 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, open-label trial of EPI-EE in chronic rhinosinusitis with nasal polyps (CRSwNP) (3 arms), sponsored by Yale University. Primary endpoint: Sinonasal Outcome Test-22 at 6 months. Started Jan 2015; status: completed.

02

Drugs

EPI-EE
03

Conditions

chronic rhinosinusitis with nasal polyps (CRSwNP)

Beyond the preview

Go deeper on NCT02194062.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02194062.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call